GlassScriptPhysician profile
Brian J Riegel
NPI 1992788657
$22,760.05
in general payments reported to CMS, 2019-2025
44 companies · $3,073 in 2025
The $3,073 reported for 2025 was more than what 88% of Nuclear Cardiology providers received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,250 · 2021: $378 · 2022: $891 · 2023: $2,146 · 2024: $1,207 · 2025: $3,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,414 · Travel and Lodging: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,413.68 |
| Travel and Lodging | $1,012.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $12,979.32 | 2019-2022 | |
| Aop Health US, LLC | $1,953.45 | 2025 | Rapiblyk |
| Heartflow, INC. | $1,407.70 | 2023-2024 | Ffrct |
| Amgen INC. | $830.45 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $677.50 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $524.03 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $517.17 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $515.51 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $356.83 | 2019-2025 | Farxiga, Wainua |
| Sanofi-Aventis U.S. LLC | $347.64 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $225.59 | 2024-2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $213.83 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $196.49 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $194.25 | 2022-2025 | Verquvo |
| Abbott Laboratories | $180.09 | 2019-2025 | Amplatzer Amulet, Aveir |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $169.24 | 2023-2024 | Cologuard Collection Kit |
| Cvrx, INC. | $157.12 | 2022-2024 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $126.23 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $118.56 | 2023-2024 | Optimizer, Optimizer |
| Lilly USA, LLC | $102.49 | 2019-2024 | Jardiance |
| Bridgebio Pharma, INC. | $102.23 | 2025 | Attruby |
| Abiomed | $91.40 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $87.51 | 2019-2025 | Evoque |
| Novo Nordisk INC | $73.11 | 2022-2023 | Wegovy |
| Scpharmaceuticals INC. | $69.62 | 2023-2025 | |
| Irhythm Technologies, INC. | $52.90 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Inspire Medical Systems, INC. | $52.90 | 2024-2025 | Inspire |
| Medicomp INC | $52.04 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.67 | 2025 | |
| Daiichi Sankyo INC. | $39.62 | 2022-2024 | Injectafer |
| Biotronik INC. | $33.19 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $32.89 | 2023 | Inpefa |
| Glaxosmithkline, LLC. | $29.05 | 2023-2025 | Arexvy, Shingrix |
| Amarin Pharma, INC. | $28.52 | 2019-2021 | |
| Gilead Sciences, INC. | $26.99 | 2019 | |
| Boston Scientific Corporation | $25.77 | 2022 | |
| Lundbeck LLC | $24.89 | 2019 | |
| Lantheus Medical Imaging, INC. | $24.84 | 2023 | Definity |
| Kiniksa Pharmaceuticals, LTD. | $17.42 | 2023 | Arcalyst |
| Bardy Diagnostics, INC. | $14.17 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $13.00 | 2025 | Rhythm Express |
| Radius Health, INC. | $12.01 | 2020 | |
| Esperion Therapeutics, INC. | $11.92 | 2022 | |
| Itamar Medical INC | $6.90 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Riegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.